No abstract available
MeSH terms
-
Adenocarcinoma / drug therapy
-
Adenocarcinoma / secondary
-
Adenocarcinoma / surgery
-
Adult
-
Aged
-
Aged, 80 and over
-
Antineoplastic Agents / adverse effects
-
Antineoplastic Agents / therapeutic use
-
Benzenesulfonates / adverse effects
-
Benzenesulfonates / therapeutic use*
-
Carcinoma, Renal Cell / drug therapy*
-
Carcinoma, Renal Cell / secondary
-
Carcinoma, Renal Cell / surgery
-
Diarrhea / chemically induced
-
Female
-
Follow-Up Studies
-
Humans
-
Kidney Neoplasms / drug therapy*
-
Kidney Neoplasms / pathology
-
Kidney Neoplasms / surgery
-
Liver Neoplasms / drug therapy*
-
Liver Neoplasms / secondary
-
Lung Neoplasms / drug therapy*
-
Lung Neoplasms / secondary
-
Male
-
Middle Aged
-
Niacinamide / analogs & derivatives
-
Phenylurea Compounds
-
Pyridines / adverse effects
-
Pyridines / therapeutic use*
-
Remission Induction
-
Sorafenib
Substances
-
Antineoplastic Agents
-
Benzenesulfonates
-
Phenylurea Compounds
-
Pyridines
-
Niacinamide
-
Sorafenib